Legal Representation
Attorney
Jordan A. LaVine
USPTO Deadlines
Next Deadline
1890 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250318)
Due Date
March 18, 2031
Grace Period Ends
September 18, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 18, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Mar 18, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 24, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Feb 24, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Feb 21, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Dec 11, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Feb 21, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Dec 11, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Aug 20, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 25, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 25, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 5, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 22, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 22, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 22, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 22, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 22, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 14, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 14, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 14, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 14, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 1, 2023 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | Loading... |
| Nov 1, 2023 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Oct 8, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 25, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Business data collection and analysis services in the field of healthcare, namely, aggregating, organizing and compiling of information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; business consulting and analysis services regarding information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; Providing business information in the field of the healthcare and life sciences industries, all of the foregoing excluding psychedelic medicines and therapies; Business consulting services to businesses in the healthcare and life sciences industries, all of the foregoing excluding psychedelic medicines and therapies
First Use Anywhere:
Mar 19, 2024
First Use in Commerce:
Mar 19, 2024
Class 042
Platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare viewing of a database with information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare the ability to model patient journeys, pathways, and care programs, all of the foregoing excluding psychedelic medicines and therapies; computer services, namely, database development services, namely, configuration and customization of databases containing information, data, statistics, insights, metrics, profiles, analytics and intelligence healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, lab data, care demographics, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; platform-as-a-service (paas) featuring computer software platforms that allow the viewing of market access insights to the life sciences industry, provide business solutions that unify pharmaceutical sales, operations, and marketing data, and provide data intelligence that aids with effective targeting, messaging, and initiatives driving sales performance, all of the foregoing excluding psychedelic medicines and therapies; Design, development and implementation of computer software for the healthcare and life sciences industry, namely, the design and development of cloud-based and application-based software for monitoring, marketing, and delivering products in the healthcare and life sciences industry, all of the foregoing excluding psychedelic medicines and therapies; Consulting services in the fields of selection, implementation and use of computer hardware and software systems for others in the health care and life science industries, all of the foregoing excluding psychedelic medicines and therapies; Business technology software consultation services in the health care and life science industries, all of the foregoing excluding psychedelic medicines and therapies; Software development and product development consulting in the field of the health care and life science industries, all of the foregoing excluding psychedelic medicines and therapies
First Use Anywhere:
Mar 19, 2024
First Use in Commerce:
Mar 19, 2024
Additional Information
Pseudo Mark
MAP VIEW
Classification
International Classes
035
042